Ion Channel Pharmacology for Pain Modulation

Handb Exp Pharmacol. 2019:260:161-186. doi: 10.1007/164_2019_336.

Abstract

A large series of different ion channels have been identified and investigated as potential targets for new medicines for the treatment of a variety of human diseases, including pain. Among these channels, the voltage gated calcium channels (VGCC) are inhibited by drugs for the treatment of migraine, neuropathic pain or intractable pain. Transient receptor potential (TRP) channels are emerging as important pain transducers as they sense low pH media or oxidative stress and other mediators and are abundantly found at sites of inflammation or tissue injury. Low pH may also activate acid sensing ion channels (ASIC) and mechanical forces stimulate the PIEZO channels. While potent agonists of TRP channels due to their desensitizing action on pain transmission are used as topical applications, the potential of TRP antagonists as pain therapeutics remains an exciting field of investigation. The study of ASIC or PIEZO channels in pain signaling is in an early stage, whereas antagonism of the purinergic P2X3 channels has been reported to provide beneficial effects in chronic intractable cough. The present chapter covers these intriguing channels in great detail, highlighting their diverse mechanisms and broad potential for therapeutic utility.

Keywords: Acid-sensing ion channels; Calcium; Ion channels; PIEZO channels; Pain; TRP.

Publication types

  • Review

MeSH terms

  • Acid Sensing Ion Channel Blockers / therapeutic use*
  • Acid Sensing Ion Channels
  • Calcium Channel Blockers / therapeutic use*
  • Calcium Channels
  • Humans
  • Inflammation
  • Neuralgia / drug therapy*
  • Pain Management*
  • Transient Receptor Potential Channels / antagonists & inhibitors*

Substances

  • Acid Sensing Ion Channel Blockers
  • Acid Sensing Ion Channels
  • Calcium Channel Blockers
  • Calcium Channels
  • Transient Receptor Potential Channels